Pith. sign in

REVIEW 3 major objections 6 minor 20 references

Stroke Lesion Segmentation using Multi-Stage Cross-Scale Attention

T0 review · 3 major / 6 minor · reviewed 2026-08-10 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read Multi-stage attention lifts small-lesion Dice across U-Net schemes

desk verdict Honest, incremental stroke-lesion paper: the existing MSCSA plug-in is shown to give consistent but small gains on small lesions across five U-Net training schemes, and the main thing to verify before trusting the headline is whether the small-lesion subset was truly held out. read the letter →

arxiv 2501.15423 v1 pith:2FU3QONY submitted 2025-01-26 eess.IV cs.CV

Liang Shang , William A. Sethares , Anusha Adluru , Andrew L. Alexander , Vivek Prabhakaran , Veena A. Nair , Nagesh Adluru This is my paper · ORCID
classification eess.IVcs.CV
keywords StrokelesionsegmentationMulti-StageCross-ScaleAttentionU-NetMRISmalldetectionATLASv2.0EnsembleSelf-training
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

This paper claims that inserting a Multi-Stage Cross-Scale Attention (MSCSA) module into U-Net skip connections reliably improves segmentation of small stroke lesions from MRI, while leaving performance on large lesions unchanged. Across four training schemes (standard, Top10-loss, Res U-Net, self-training), adding MSCSA raises Dice and F1 on a 138-image small-lesion subset, and the ensemble with MSCSA achieves the best overall scores on both the small subset and the full 655-image dataset. The authors argue that multi-stage feature concatenation and cross-scale attention let the network relate features across scales, which matters because small lesions are the hardest cases and the most relevant for early-stage clinical assessment. If right, the module is a drop-in upgrade for any U-Net-based segmentation pipeline.

What carries the argument

The Multi-Stage Cross-Scale Attention (MSCSA) block, inserted in place of U-Net's skip connections. It takes encoder feature maps from several stages, resamples them to a common resolution, concatenates them along channels, and runs them through Cross-Scale Attention (CSA) followed by an Intra-Feed-Forward Network (Intra-FFN), with a second CSA+FFN stage. CSA uses Multi-Scale key and value Projection (MSP) to build keys/values at three scales, and Relational Positional Encoding (RPE) via depth-wise convolution to preserve local spatial structure; Intra-FFN splits the 1120-channel multi-stage map into per-stage segments to keep compute manageable. The refined maps are split back to original resolutions and fused with encoder features to feed the decoder.

What would settle it

Re-run the 5-fold cross-validation with the 138 small-lesion images strictly excluded from all training folds; if the reported Dice and F1 advantages on that subset shrink or disappear, the small-lesion claim is an artifact of data leakage. Alternatively, evaluate the trained models on an external cohort of small stroke lesions not used in training.

Watch

Extended reading notes

Core claim

The central claim is that MSCSA, a plug-in module that replaces direct skip connections between encoder and decoder, makes U-Net-family models better at detecting small stroke lesions without a trade-off on larger lesions. The paper reports consistent Dice/F1 gains on the small-lesion subset (lesions under 1,000 voxels) across Default, Res U-Net, Self-Training, and Ensemble schemes, with Ensemble+MSCSA scoring highest on both the full dataset and the small subset. The mechanism is described as establishing multi-stage interactions by concatenating encoder feature maps of different resolutions and cross-scale interactions by constructing multi-scale key/value projections in attention, so the network can relate objects of different sizes.

Load-bearing premise

The gains on the small-lesion subset depend on the 138 small-lesion images never being used in the training fold that produces each prediction, and the paper does not explicitly confirm that held-out separation.

Editorial extensions

If this is right

  • Small lesion Dice and F1 improve across all four training schemes when MSCSA is added, with the largest absolute gains on the self-training scheme.
  • Ensemble+MSCSA achieves the highest Dice and F1 scores on both the full ATLAS v2.0 dataset and the small-lesion subset, making it the strongest configuration tested.
  • Because the module works with Default, DTK10, Res U-Net, and Self-Training schemes, the benefit does not depend on one specific training recipe.
  • The reported gains suggest a plug-in route to better small-lesion segmentation without redesigning the whole architecture.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • The small-lesion subset is carved out of the same 655-image dataset that feeds the 5-fold cross-validation, so the reported gains assume the 138 images never appear in the training fold used to produce their predictions; the paper does not explicitly confirm this held-out separation.
  • If the held-out assumption holds, the mechanism might transfer to other small-lesion domains such as multiple sclerosis lesion segmentation, which the authors name as a planned extension.
  • A natural test is to measure whether the gain concentrates on the smallest lesions in the subset or is spread uniformly, since cross-scale attention should most help tiny structures.
  • The cost of the module (extra parameters and compute from the 1120-channel multi-stage map) is not reported; the practical case for adoption would need that trade-off quantified.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

3 major / 6 minor

Summary. This paper proposes applying a plug-in Multi-Stage Cross-Scale Attention (MSCSA) module to U-Net-style stroke lesion segmentation networks. The module is inserted in place of standard skip connections, fusing multi-stage encoder features and using cross-scale attention with relational positional encoding. The authors evaluate MSCSA on the ATLAS v2.0 dataset under five training schemes: a default U-Net, a Top-10 CE loss variant (DTK10), Res U-Net, self-training, and an ensemble of all models. For each scheme they compare baseline versus baseline+MSCSA on the full 655-image cross-validation set and on a 138-image subset of lesions under 1,000 voxels. The reported results show that MSCSA yields small full-dataset differences (Dice changes of approximately -0.005 to +0.003) but consistent improvements on the small-lesion subset for both Dice and F1, with the largest gains for Ensemble+MSCSA (small-lesion Dice 0.458 vs. 0.439, F1 0.574 vs. 0.537). The paper claims that MSCSA significantly outperforms baselines on small lesions while remaining competitive on the full dataset.

Significance. If the small-lesion gains are real and reflect held-out generalization, MSCSA would be a useful plug-in component for improving small-lesion stroke segmentation across a range of U-Net training strategies. The study's strengths are its use of the public ATLAS v2.0 benchmark, evaluation across five training schemes, and release of code. The manuscript also avoids circular evaluation: the ATLAS test labels are not used to fit the models. However, the central claim rests on the small-lesion subset, and the paper does not report any statistical tests, confidence intervals, or per-fold variability, while the full-dataset differences are tiny (0.001-0.003 Dice). The significance of the work is therefore conditional on clarifying the evaluation protocol and demonstrating that the small-lesion improvements are not due to chance or inadvertent in-sample evaluation.

major comments (3)
  1. The small-lesion evaluation protocol is ambiguous in a load-bearing way. The Dataset section states that 138 MRIs with lesions under 1,000 voxels were selected from the 655-image ATLAS training set 'to create a dedicated testing subset,' but the Implementation details describe a 5-fold size-balanced cross-validation over the entire 655-image set. The paper never explicitly states whether the small-lesion metrics are computed exclusively from predictions on the validation fold in which each of these 138 images appears (i.e., from a model trained without that image), or whether some or all of the small-lesion predictions come from models that saw these images during training. If the latter is the case, the reported gains (e.g., Dice +0.019 and F1 +0.037 for Ensemble+MSCSA) would reflect in-sample performance rather than generalization. Please state the exact protocol for the small-lesion subset and confirm that every small-lesion prediction was made by a model whose training folds excluded that image; if this is not the case, the small-lesion experiments need to be redone with proper held-out splits.
  2. The caption asserts that MSCSA 'significantly outperforms' the baselines on the small-lesion subset in all metrics, but the paper provides no statistical test, confidence interval, or per-fold standard deviation to support the word 'significantly.' Given that the full-dataset differences are only 0.001-0.003 Dice and the small-lesion gains are modest, statistical significance cannot be inferred from the point estimates alone. Please report per-fold results and a paired test across the 138 small-lesion cases (or across folds), such as a Wilcoxon signed-rank test or bootstrap confidence intervals, and temper the language if significance is not established.
  3. The full-dataset comparison for Res U-Net shows that MSCSA decreases Dice from 0.638 to 0.633, yet the text in Section 3 states that 'MSCSA demonstrates competitive and comparable performance with the baselines' without noting this decrease. This is relevant to the claim that MSCSA maintains performance on large lesions without compromise. Please acknowledge this decrease explicitly and discuss whether it is within expected variability, or report per-fold results that put the difference in context.
minor comments (6)
  1. The sentence 'As shown in 1, MSCSA surpasses...' should read 'As shown in Table 1.'
  2. The caption uses 'DEConv' while the text in Section 2 uses 'DWConv'; please use consistent terminology for depth-wise convolution.
  3. The formulas for h2, h3, w2, w3, d2, d3 use division without explicit floor or integer-division notation; please clarify that these are integer operations, since the equations as written suggest non-integer spatial dimensions.
  4. The self-training scheme uses an additional 300 unlabeled MRIs from the ATLAS test set to generate pseudo-masks. This should be disclosed as a semi-supervised/transductive element of that training scheme, because it uses data outside the 655-image training set and may affect comparability with the other schemes that do not use unlabeled test-set data.
  5. The 'Top10 CE loss' (DTK10) is not defined or referenced; please provide a definition or citation so that the loss modification is reproducible.
  6. The discussion mentions that MS lesions 'typically fall below 1000 mm3,' but the paper's small-lesion threshold is defined in voxels; please clarify the voxel-to-volume relationship or rephrase to avoid mixing units.

Circularity Check

0 steps flagged · score 0.0 of 10

No circularity: the reported gains rest on external ATLAS v2.0 evaluation, not on a fitted parameter or a self-citation chain.

full rationale

The paper's central claim is an empirical comparison of U-Net variants with and without the MSCSA module on the external ATLAS v2.0 dataset. The Dice and F1 numbers in Table 1 are computed from model outputs against ground-truth lesion masks; no equation in the paper derives these metrics from the inputs by construction. The only self-citation is reference [6], which is the authors' prior MSCSA proposal, but the current paper uses that module as an architectural component and evaluates it independently on a public benchmark rather than invoking [6] as proof of effectiveness. The small-lesion subset is a hand-selected analysis subgroup, and one could question whether its images were properly held out in the 5-fold cross-validation, but that is a validity or leakage concern, not a circularity of the form 'X is defined in terms of Y' or 'a fitted parameter is renamed as a prediction.' No self-definitional reduction, no imported uniqueness theorem, and no ansatz smuggled in via citation appear in the derivation chain. Therefore the circularity score is 0.

Assumptions & free parameters 6 free parameters · 4 assumptions · 0 invented entities

The evaluation rests on the ATLAS v2.0 ground truth, the size-balanced 5-fold split from [8], and the correctness of the nnU-Net and MSCSA implementations. The paper introduces no new physical entities. The main hand-set choices are the 1,000-voxel threshold for the small-lesion subset, the target scale for multi-stage feature maps, the three-branch scale decomposition, and the standard SGD training hyperparameters.

free parameters (6)
  • small lesion volume threshold = 1000 voxels
    Hand-chosen cutoff for the small-lesion subset; directly determines which cases are included in the headline comparison.
  • target feature map size in MSCSA = not explicitly stated in text (figure implies ~128x128x8)
    Encoder outputs are resized to a uniform scale before cross-scale attention; this scale is a design choice.
  • number of scales in Multi-Scale Projection = 3
    Eq. (1) defines original, half, and third resolution branches; fixed without ablation.
  • Intra-FFN replacement ratio = 1/2
    Half of FFNs are replaced with Intra-FFNs to reduce compute; no ablation on this ratio.
  • training hyperparameters = lr=0.01, momentum=0.99, batch=2, epochs=1000, patch=128^3
    Standard SGD settings shared with baselines, but still hand-chosen.
  • Dice+CE loss weight = not reported
    The combined loss weighting is not specified; it affects the balance between small and large lesion training signals.
assumptions (4)
  • domain assumption ATLAS v2.0 segmentation masks are accurate ground truth
    The evaluation treats manual tracings as correct; errors would affect all methods but alter absolute scores.
  • domain assumption The size-balanced 5-fold split is representative
    The paper follows [8]'s split; if the split is unbalanced, the small-lesion subgroup could be biased.
  • domain assumption nnU-Net and MSCSA implementations are correct
    Results depend on the correctness of the nnU-Net framework and the ported MSCSA module from [6].
  • standard math Standard deep learning operations and backpropagation are correct
    The paper relies on standard attention and convolution without proving these operations.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Stroke Lesion Segmentation using Multi-Stage Cross-Scale Attention." pith.science (2026). https://pith.science/paper/2FU3QONY

@misc{pith2026250115423,
  author       = {Pith},
  title        = {Pith review of: Stroke Lesion Segmentation using Multi-Stage Cross-Scale Attention},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/2FU3QONY}},
  note         = {Machine review of arXiv:2501.15423}
}
read the original abstract

Precise characterization of stroke lesions from MRI data has immense value in prognosticating clinical and cognitive outcomes following a stroke. Manual stroke lesion segmentation is time-consuming and requires the expertise of neurologists and neuroradiologists. Often, lesions are grossly characterized for their location and overall extent using bounding boxes without specific delineation of their boundaries. While such characterization provides some clinical value, to develop a precise mechanistic understanding of the impact of lesions on post-stroke vascular contributions to cognitive impairments and dementia (VCID), the stroke lesions need to be fully segmented with accurate boundaries. This work introduces the Multi-Stage Cross-Scale Attention (MSCSA) mechanism, applied to the U-Net family, to improve the mapping between brain structural features and lesions of varying sizes. Using the Anatomical Tracings of Lesions After Stroke (ATLAS) v2.0 dataset, MSCSA outperforms all baseline methods in both Dice and F1 scores on a subset focusing on small lesions, while maintaining competitive performance across the entire dataset. Notably, the ensemble strategy incorporating MSCSA achieves the highest scores for Dice and F1 on both the full dataset and the small lesion subset. These results demonstrate the effectiveness of MSCSA in segmenting small lesions and highlight its robustness across different training schemes for large stroke lesions. Our code is available at: https://github.com/nadluru/StrokeLesSeg.

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

20 extracted references · 15 canonical work pages

  1. [6]

    Ethical approval was not required as con- firmed by the license attached with the open access data

    COMPLIANCE WITH ETHICAL STANDARDS This research study was conducted retrospectively using hu- man subject data (ATLAS v2.0 [7]) made available in open access under the Creative Commons Attribution 4.0 Interna- tional License 1. Ethical approval was not required as con- firmed by the license attached with the open access data

    work page

  2. [1]

    Stroke Lesion Segmentation using Multi-Stage Cross-Scale Attention

    INTRODUCTION Strokes are caused by an insufficient supply of blood to cer- tain parts of the brain. The localization and quantification of the injured tissue (lesion), as well as the “penumbra” (the at-risk peripheral tissue) using Magnetic Resonance Imaging (MRI), is fundamental to providing a prognosis and devel- oping individualized recovery and rehabi...

    work page Pith review arXiv 2025

  3. [2]

    Our frame- work builds upon the MSCSA [6] and nnU-Net [8, 9], allow- ing seamless integration with the broader U-Net family

    METHODS Multi-Stage Cross-Scale Attention (MSCSA). Our frame- work builds upon the MSCSA [6] and nnU-Net [8, 9], allow- ing seamless integration with the broader U-Net family. As depicted in Fig. 1(a), the MSCSA serves as an add-on mod- ule, replacing direct connections between the U-Net’s en- coder and decoder. Feature maps of varying resolutions from th...

    work page

  4. [3]

    RESULTS Performance on the entire dataset We first present the eval- uation of MSCSA using 5-fold cross-validation on the entire dataset, as outlined in Table 1. In the Default, DTK10, Res U- Net, and Self-Training schemes, MSCSA demonstrates com- L R Image Default DTK10 Res U-Net Self-Training Ensemble Image Default with MSCSA DTK10 with MSCSA Res U-Net ...

    work page

  5. [4]

    MSCSA demon- strated improved efficacy in detecting and segmenting small lesions while maintaining competitive performance with a wide variety of training schemes for large lesions

    DISCUSSION This study integrated the Multi-Stage Cross-Scale Attention (MSCSA) module into the U-Net family for stroke lesion segmentation from T 1 weighted MRI data. MSCSA demon- strated improved efficacy in detecting and segmenting small lesions while maintaining competitive performance with a wide variety of training schemes for large lesions. The pro-...

    work page

  6. [5]

    ACKNOWLEDGEMENTS The following NIH grants are acknowledged: R01NS123378, R01NS111022, R01NS105646, R01NS117568, and P50HD105353

    work page

  7. [7]

    U-net: Convolutional networks for biomedical im- age segmentation,

    Olaf Ronneberger, Philipp Fischer, and Thomas Brox, “U-net: Convolutional networks for biomedical im- age segmentation,” in Medical Image Computing and Computer-Assisted Intervention–MICCAI 2015: 18th International Conference, Munich, Germany, October 5-9, 2015, Proceedings, Part III 18. Springer, 2015, pp. 234–241

    work page 2015

  8. [8]

    Attention is all you need,

    Ashish Vaswani, Noam Shazeer, Niki Parmar, Jakob Uszkoreit, Llion Jones, Aidan N Gomez, Lukasz Kaiser, and Illia Polosukhin, “Attention is all you need,” Ad- vances in neural information processing systems , vol. 30, 2017

    2017

Show all 20 references
  1. [9]

    An image is worth 16x16 words: Transformers for image recognition at scale,

    Alexey Dosovitskiy, Lucas Beyer, Alexander Kolesnikov, Dirk Weissenborn, Xiaohua Zhai, Thomas Unterthiner, Mostafa Dehghani, Matthias Minderer, Georg Heigold, Sylvain Gelly, et al., “An image is worth 16x16 words: Transformers for image recognition at scale,” arXiv preprint ar...

    2010 arXiv

  2. [10]

    Swin unetr: Swin transformers for semantic segmentation of brain tumors in mri images,

    Ali Hatamizadeh, Vishwesh Nath, Yucheng Tang, Dong Yang, Holger R Roth, and Daguang Xu, “Swin unetr: Swin transformers for semantic segmentation of brain tumors in mri images,” in International MICCAI brain- lesion workshop. Springer, 2021, pp. 272–284

    2021

  3. [11]

    Unetr: Transformers for 3d medical image segmentation,

    Ali Hatamizadeh, Yucheng Tang, Vishwesh Nath, Dong Yang, Andriy Myronenko, Bennett Landman, Holger R Roth, and Daguang Xu, “Unetr: Transformers for 3d medical image segmentation,” in Proceedings of the IEEE/CVF winter conference on applications of com- puter vision, 2022, pp. 574–584

    2022

  4. [12]

    Vision backbone enhancement via multi-stage cross- scale attention,

    Liang Shang, Yanli Liu, Zhengyang Lou, Shuxue Quan, Nagesh Adluru, Bochen Guan, and William A Sethares, “Vision backbone enhancement via multi-stage cross- scale attention,” arXiv preprint arXiv:2308.05872 , 2023. 1http://creativecommons.org/licenses/by/4.0/

    2023 arXiv

  5. [13]

    A large, curated, open-source stroke neuroimaging dataset to improve le- sion segmentation algorithms,

    Sook-Lei Liew, Bethany P Lo, Miranda R Don- nelly, Artemis Zavaliangos-Petropulu, Jessica N Jeong, Giuseppe Barisano, Alexandre Hutton, Julia P Simon, Julia M Juliano, Anisha Suri, et al., “A large, curated, open-source stroke neuroimaging dataset to improve le- sion segmentat...

    2022

  6. [14]

    Mapping: Model average with post-processing for stroke lesion segmentation,

    Jiayu Huo, Liyun Chen, Yang Liu, Maxence Boels, Alejandro Granados, Sebastien Ourselin, and Rachel Sparks, “Mapping: Model average with post-processing for stroke lesion segmentation,” arXiv preprint arXiv:2211.15486, 2022

    2022 arXiv

  7. [15]

    nnu-net: a self- configuring method for deep learning-based biomedical image segmentation,

    Fabian Isensee, Paul F Jaeger, Simon AA Kohl, Jens Petersen, and Klaus H Maier-Hein, “nnu-net: a self- configuring method for deep learning-based biomedical image segmentation,” Nature methods, vol. 18, no. 2, pp. 203–211, 2021

    2021

  8. [16]

    Multi-scale high-resolution vision trans- former for semantic segmentation,

    Jiaqi Gu, Hyoukjun Kwon, Dilin Wang, Wei Ye, Meng Li, Yu-Hsin Chen, Liangzhen Lai, Vikas Chandra, and David Z Pan, “Multi-scale high-resolution vision trans- former for semantic segmentation,” in Proceedings of the IEEE/CVF Conference on Computer Vision and Pat- tern Recogniti...

    2022

  9. [17]

    A probabilistic atlas and reference system for the human brain: Inter- national consortium for brain mapping (icbm),

    John Mazziotta, Arthur Toga, Alan Evans, Peter Fox, Jack Lancaster, Karl Zilles, Roger Woods, Tomas Paus, Gregory Simpson, Bruce Pike, et al., “A probabilistic atlas and reference system for the human brain: Inter- national consortium for brain mapping (icbm),” Philo- sophical...

    2001

  10. [18]

    Pytorch: An imperative style, high-performance deep learning library,

    Adam Paszke, Sam Gross, Francisco Massa, Adam Lerer, James Bradbury, Gregory Chanan, Trevor Killeen, Zeming Lin, Natalia Gimelshein, Luca Antiga, et al., “Pytorch: An imperative style, high-performance deep learning library,” Advances in neural information processing systems, ...

    2019

  11. [19]

    Segmenting small stroke lesions with novel labeling strategies,

    Liang Shang, Zhengyang Lou, Andrew L Alexander, Vivek Prabhakaran, William A Sethares, Veena A Nair, and Nagesh Adluru, “Segmenting small stroke lesions with novel labeling strategies,” in International Work- shop on Machine Learning in Clinical Neuroimaging . Springer, 2025, ...

    2025

  12. [20]

    Icpr 2024 competition on multiple sclerosis lesion segmentation—methods and results,

    Alessia Rondinella, Francesco Guarnera, Elena Crispino, Giulia Russo, Clara Di Lorenzo, Davide Mai- mone, Francesco Pappalardo, and Sebastiano Battiato, “Icpr 2024 competition on multiple sclerosis lesion segmentation—methods and results,” in International Conference on Patter...

    2024

Pith tools

Reviewed August 10, 2026 · model on record in the stance chip above.